Post Reply
81-100 of 235
Contra players die.. All need to pick up.
maybe wait for news...
today clear 2?
Nice closing @ 0.002. Huat!!!
SLOW & STEADY?
SmallSmall ( Date: 24-Nov-2020 10:57) Posted:
| Chipping down the wall at $0.002 now ...... |
|
Chipping down the wall at $0.002 now ......
0.4cents is good
Operator81 ( Date: 24-Nov-2020 07:23) Posted:
It went up to 0.3 - 0.4 cents in early year 2019. This time round, i have no target.
ThankYou ( Date: 23-Nov-2020 21:15) Posted:
| If they can report profitable earnings then it will go faster. I remember it went up to 0.1-0.2 before coming back to 0-0.1. This time it might be staying at 0.1-0.2 for a while. |
|
|
|
It went up to 0.3 - 0.4 cents in early year 2019. This time round, i have no target.
ThankYou ( Date: 23-Nov-2020 21:15) Posted:
If they can report profitable earnings then it will go faster. I remember it went up to 0.1-0.2 before coming back to 0-0.1. This time it might be staying at 0.1-0.2 for a while.
redbull888 ( Date: 23-Nov-2020 21:07) Posted:
this is a min 0.004 - 0.007
my PO |
|
|
|
If they can report profitable earnings then it will go faster. I remember it went up to 0.1-0.2 before coming back to 0-0.1. This time it might be staying at 0.1-0.2 for a while.
redbull888 ( Date: 23-Nov-2020 21:07) Posted:
this is a min 0.004 - 0.007
my POV
sklong138 ( Date: 23-Nov-2020 19:45) Posted:
| Based on the recent financial statement extracted from the report & reproduce below, it appears to be positive on the share price with some 253 million share traded today from 0.001 & close at 0.002 & further more the Chairman & Directors also bought significant amount of shares in Oct 2020. Must be a good sign as the Chairman & Directors have strong confidence in the company performance over the next 12 months.
The following events are expected to positively impact the Group in the next reporting period and the next 12 months:
(i) Acquisition of New Subsidiaries/Joint Venture Companies Acquisition of Beverly Wilshire Medical Centre Group Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru. Formation of Strategic Joint Venture with Natasha Skincare (Malaysia) Sdn Bhd The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 24 January 2020, incorporated an SPV, Natasha Beverly Sdn Bhd, for the purposes of forming a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Formation of Strategic Joint Venture with Dr Chong Yee Leng The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 7 April 2020 incorporated an SPV, Beverly Ipoh Sdn Bhd for the purposes of forming a strategic joint venture with Dr Chong Yee Leng. The joint venture&rsquo s principal activities are aesthetic medicine and related activities. Barring any unforeseen circumstances, the Group expects the new subsidiary corporations/joint venture companies to contribute positively to the Group&rsquo s revenue, profits and working capital in the next reporting period and in the next 12 months. Page 19 Formation of Strategic Joint Venture with Dermatology & Surgery Clinic Pte Ltd Natasha Beverly had on 15 July 2020 incorporated an SPV, DS Beverly Sdn Bhd (&ldquo DS Beverly&rdquo ), for the purposes of forming a strategic joint venture with Dermatology & Surgery Clinic Pte Ltd (&ldquo DS&rdquo ), who is an unrelated third party. The joint venture&rsquo s principal activities include healthy aging, regenerative medicine and health screening services. Natasha Beverly had on 21 August 2020 entered into a non-binding term sheet and on 24 August 2020 entered into a supplemental letter (collectively, the &ldquo Term Sheet&rdquo ) with DS to establish a joint venture for the purposes of providing healthy aging, regenerative medicine and health screening service |
|
|
|
this is a min 0.004 - 0.007
my POV
sklong138 ( Date: 23-Nov-2020 19:45) Posted:
Based on the recent financial statement extracted from the report & reproduce below, it appears to be positive on the share price with some 253 million share traded today from 0.001 & close at 0.002 & further more the Chairman & Directors also bought significant amount of shares in Oct 2020. Must be a good sign as the Chairman & Directors have strong confidence in the company performance over the next 12 months.
The following events are expected to positively impact the Group in the next reporting period and the next 12 months:
(i) Acquisition of New Subsidiaries/Joint Venture Companies Acquisition of Beverly Wilshire Medical Centre Group Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru. Formation of Strategic Joint Venture with Natasha Skincare (Malaysia) Sdn Bhd The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 24 January 2020, incorporated an SPV, Natasha Beverly Sdn Bhd, for the purposes of forming a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Formation of Strategic Joint Venture with Dr Chong Yee Leng The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 7 April 2020 incorporated an SPV, Beverly Ipoh Sdn Bhd for the purposes of forming a strategic joint venture with Dr Chong Yee Leng. The joint venture&rsquo s principal activities are aesthetic medicine and related activities. Barring any unforeseen circumstances, the Group expects the new subsidiary corporations/joint venture companies to contribute positively to the Group&rsquo s revenue, profits and working capital in the next reporting period and in the next 12 months. Page 19 Formation of Strategic Joint Venture with Dermatology & Surgery Clinic Pte Ltd Natasha Beverly had on 15 July 2020 incorporated an SPV, DS Beverly Sdn Bhd (&ldquo DS Beverly&rdquo ), for the purposes of forming a strategic joint venture with Dermatology & Surgery Clinic Pte Ltd (&ldquo DS&rdquo ), who is an unrelated third party. The joint venture&rsquo s principal activities include healthy aging, regenerative medicine and health screening services. Natasha Beverly had on 21 August 2020 entered into a non-binding term sheet and on 24 August 2020 entered into a supplemental letter (collectively, the &ldquo Term Sheet&rdquo ) with DS to establish a joint venture for the purposes of providing healthy aging, regenerative medicine and health screening services
ThankYou ( Date: 23-Nov-2020 19:34) Posted:
| Is the share price going to U turn |
|
|
|
👍 Meaning U turn up
sklong138 ( Date: 23-Nov-2020 19:45) Posted:
Based on the recent financial statement extracted from the report & reproduce below, it appears to be positive on the share price with some 253 million share traded today from 0.001 & close at 0.002 & further more the Chairman & Directors also bought significant amount of shares in Oct 2020. Must be a good sign as the Chairman & Directors have strong confidence in the company performance over the next 12 months.
The following events are expected to positively impact the Group in the next reporting period and the next 12 months:
(i) Acquisition of New Subsidiaries/Joint Venture Companies Acquisition of Beverly Wilshire Medical Centre Group Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru. Formation of Strategic Joint Venture with Natasha Skincare (Malaysia) Sdn Bhd The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 24 January 2020, incorporated an SPV, Natasha Beverly Sdn Bhd, for the purposes of forming a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Formation of Strategic Joint Venture with Dr Chong Yee Leng The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 7 April 2020 incorporated an SPV, Beverly Ipoh Sdn Bhd for the purposes of forming a strategic joint venture with Dr Chong Yee Leng. The joint venture&rsquo s principal activities are aesthetic medicine and related activities. Barring any unforeseen circumstances, the Group expects the new subsidiary corporations/joint venture companies to contribute positively to the Group&rsquo s revenue, profits and working capital in the next reporting period and in the next 12 months. Page 19 Formation of Strategic Joint Venture with Dermatology & Surgery Clinic Pte Ltd Natasha Beverly had on 15 July 2020 incorporated an SPV, DS Beverly Sdn Bhd (&ldquo DS Beverly&rdquo ), for the purposes of forming a strategic joint venture with Dermatology & Surgery Clinic Pte Ltd (&ldquo DS&rdquo ), who is an unrelated third party. The joint venture&rsquo s principal activities include healthy aging, regenerative medicine and health screening services. Natasha Beverly had on 21 August 2020 entered into a non-binding term sheet and on 24 August 2020 entered into a supplemental letter (collectively, the &ldquo Term Sheet&rdquo ) with DS to establish a joint venture for the purposes of providing healthy aging, regenerative medicine and health screening services
ThankYou ( Date: 23-Nov-2020 19:34) Posted:
| Is the share price going to U turn |
|
|
|
Based on the recent financial statement extracted from the report & reproduce below, it appears to be positive on the share price with some 253 million share traded today from 0.001 & close at 0.002 & further more the Chairman & Directors also bought significant amount of shares in Oct 2020. Must be a good sign as the Chairman & Directors have strong confidence in the company performance over the next 12 months.
The following events are expected to positively impact the Group in the next reporting period and the next 12 months:
(i) Acquisition of New Subsidiaries/Joint Venture Companies Acquisition of Beverly Wilshire Medical Centre Group Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru. Formation of Strategic Joint Venture with Natasha Skincare (Malaysia) Sdn Bhd The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 24 January 2020, incorporated an SPV, Natasha Beverly Sdn Bhd, for the purposes of forming a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Formation of Strategic Joint Venture with Dr Chong Yee Leng The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 7 April 2020 incorporated an SPV, Beverly Ipoh Sdn Bhd for the purposes of forming a strategic joint venture with Dr Chong Yee Leng. The joint venture&rsquo s principal activities are aesthetic medicine and related activities. Barring any unforeseen circumstances, the Group expects the new subsidiary corporations/joint venture companies to contribute positively to the Group&rsquo s revenue, profits and working capital in the next reporting period and in the next 12 months. Page 19 Formation of Strategic Joint Venture with Dermatology & Surgery Clinic Pte Ltd Natasha Beverly had on 15 July 2020 incorporated an SPV, DS Beverly Sdn Bhd (&ldquo DS Beverly&rdquo ), for the purposes of forming a strategic joint venture with Dermatology & Surgery Clinic Pte Ltd (&ldquo DS&rdquo ), who is an unrelated third party. The joint venture&rsquo s principal activities include healthy aging, regenerative medicine and health screening services. Natasha Beverly had on 21 August 2020 entered into a non-binding term sheet and on 24 August 2020 entered into a supplemental letter (collectively, the &ldquo Term Sheet&rdquo ) with DS to establish a joint venture for the purposes of providing healthy aging, regenerative medicine and health screening services
ThankYou ( Date: 23-Nov-2020 19:34) Posted:
Is the share price going to U turn?
sklong138 ( Date: 23-Nov-2020 19:10) Posted:
| Nice closing at 0.002. Huat!!! |
|
|
|
Is the share price going to U turn?
sklong138 ( Date: 23-Nov-2020 19:10) Posted:
| Nice closing at 0.002. Huat!!! |
|
Nice closing at 0.002. Huat!!!
SmallSmall ( Date: 23-Nov-2020 13:15) Posted:
Substantial shareholder Dato Ng Tian Sang bought 45.7 mil @ $0.001 on 1st Oct 2020 and a further 50 mil @ $0.001 on 12 Oct 2020.
$0.001 should be a safe entry point for this counter for a 100% return :) |
|
slowly eating the 2s
Substantial shareholder Dato Ng Tian Sang bought 45.7 mil @ $0.001 on 1st Oct 2020 and a further 50 mil @ $0.001 on 12 Oct 2020.
$0.001 should be a safe entry point for this counter for a 100% return :)
Huat to all vested.
Extracted from recent financial statement
The following events are expected to positively impact the Group in the next reporting period and the next 12 months:
(i) Acquisition of New Subsidiaries/Joint Venture Companies Acquisition of Beverly Wilshire Medical Centre Group Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru. Formation of Strategic Joint Venture with Natasha Skincare (Malaysia) Sdn Bhd The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 24 January 2020, incorporated an SPV, Natasha Beverly Sdn Bhd, for the purposes of forming a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Formation of Strategic Joint Venture with Dr Chong Yee Leng The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd had on 7 April 2020 incorporated an SPV, Beverly Ipoh Sdn Bhd for the purposes of forming a strategic joint venture with Dr Chong Yee Leng. The joint venture&rsquo s principal activities are aesthetic medicine and related activities. Barring any unforeseen circumstances, the Group expects the new subsidiary corporations/joint venture companies to contribute positively to the Group&rsquo s revenue, profits and working capital in the next reporting period and in the next 12 months. Page 19 Formation of Strategic Joint Venture with Dermatology & Surgery Clinic Pte Ltd Natasha Beverly had on 15 July 2020 incorporated an SPV, DS Beverly Sdn Bhd (&ldquo DS Beverly&rdquo ), for the purposes of forming a strategic joint venture with Dermatology & Surgery Clinic Pte Ltd (&ldquo DS&rdquo ), who is an unrelated third party. The joint venture&rsquo s principal activities include healthy aging, regenerative medicine and health screening services. Natasha Beverly had on 21 August 2020 entered into a non-binding term sheet and on 24 August 2020 entered into a supplemental letter (collectively, the &ldquo Term Sheet&rdquo ) with DS to establish a joint venture for the purposes of providing healthy aging, regenerative medicine and health screening services
251 mil done
